Manzo Pharmaceuticals, Inc.
MNZO
Rank in Stocks
#32925
Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the... Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the discovery, creation, and evaluation of both proprietary and generic medical treatments and therapies. The company is actively developing Lacto-Freedom, a patented probiotic designed to help individuals with lactose intolerance digest dairy-containing foods more easily. Additionally, it is crafting a natural solution for infant colic. Headquartered in Milford, Pennsylvania, the organization was formerly known as Fortune Oil & Gas, Inc. before adopting its current name, Manzo Pharmaceuticals, Inc., in September 2014.
Share Price
$0.0002
Last synced: 2026-11-12
Market Cap
$1,000.00K
Change (1 day)
0.00%
Change (1 year)
100.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Manzo Pharmaceuticals, Inc. (MNZO)
Category
Healthcare
Operating Margin for Manzo Pharmaceuticals, Inc. (MNZO)
Operating Margin as of November 2026 TTM: 0.00%
According to Manzo Pharmaceuticals, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Manzo Pharmaceuticals, Inc. from 2003 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | -100.00% |
| 2015 | 39.37% | -100.09% |
| 2014 | -44,856.39% | 42,964.89% |
| 2004 | -104.16% | -3.68% |
| 2003 | -108.14% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | - |
DE
|
|
| 19.68% | - |
DE
|
|
| 13.26% | - |
JP
|
|
| 17.08% | - |
CH
|
|
| 14.92% | - |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Manzo Pharmaceuticals, Inc.'s operating margin
What was Manzo Pharmaceuticals, Inc.'s operating margin in 2025?
In 2025, Manzo Pharmaceuticals, Inc.'s operating margin was 0.00%, compared with 39.37% in 2015.
How does Manzo Pharmaceuticals, Inc.'s operating margin compare with similar companies?
Manzo Pharmaceuticals, Inc.'s operating margin (0.00%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.